Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9226
CALL
IDEAYA Biosciences
IDYA
$3.53B
| $506K | ﹤0.01% |
15,200
-21,400
| -58% | -$718K |
2021 Q4
17 quarters
|
|
|
IAUI
9227
PUT
NEOS Gold High Income ETF
IAUI
$571M
| $506K | ﹤0.01% |
8,900
-100
| -1% | -$6K |
2025 Q4
1 quarter
|
|
9228
PrimeEnergy Resources
PNRG
$333M
| $506K | ﹤0.01% |
+2,173
| New | +$418K |
2026 Q1
0 quarters
|
|
9229
PUT
Direxion Daily NYSE FANG+ Bull 2X ETF
FNGG
$123M
| $506K | ﹤0.01% |
3,300
-4,100
| -55% | -$736K |
2025 Q1
4 quarters
|
|
9230
PUT
The Greenbrier Companies
GBX
$1.24B
| $505K | ﹤0.01% |
9,600
-5,600
| -37% | -$296K |
2013 Q2
51 quarters
|
|
9231
Sera Prognostics
SERA
$80.9M
| $505K | ﹤0.01% |
248,909
-458,705
| -65% | -$1.18M |
2024 Q4
5 quarters
|
|
9232
CALL
Saratoga Investment
SAR
$254M
| $505K | ﹤0.01% |
23,100
+14,400
| +166% | +$331K |
2022 Q2
15 quarters
|
|
9233
PUT
Compass Therapeutics
CMPX
$180M
| $505K | ﹤0.01% |
+95,500
| New | +$551K |
2026 Q1
0 quarters
|
|
9234
CALL
Phillips Edison & Co
PECO
$4.83B
| $505K | ﹤0.01% |
+13,500
| New | +$502K |
2026 Q1
0 quarters
|
|
9235
CALL
CNO Financial Group
CNO
$5B
| $505K | ﹤0.01% |
12,300
+5,700
| +86% | +$238K |
2022 Q4
13 quarters
|
|
9236
CALL
Monte Rosa Therapeutics
GLUE
$842M
| $505K | ﹤0.01% |
30,700
+12,000
| +64% | +$229K |
2022 Q4
13 quarters
|
|
9237
Angel Oak High Yield Opportunities ETF
AOHY
$116M
| $505K | ﹤0.01% |
+46,190
| New | +$513K |
2026 Q1
0 quarters
|
|
9238
iShares MSCI UAE ETF
UAE
$321M
| $505K | ﹤0.01% |
+27,065
| New | +$541K |
2026 Q1
0 quarters
|
|
9239
CALL
Absci
ABSI
$1.76B
| $505K | ﹤0.01% |
168,200
-108,200
| -39% | -$313K |
2022 Q3
14 quarters
|
|
9240
CALL
CGI
GIB
$14.4B
| $504K | ﹤0.01% |
6,900
-8,200
| -54% | -$655K |
2017 Q4
33 quarters
|
|
9241
Amplify Mobile Payments ETF
IPAY
$150M
| $504K | ﹤0.01% |
+11,780
| New | +$554K |
2026 Q1
0 quarters
|
|
9242
First Trust SkyBridge Crypto Industry and Digital Economy ETF
CRPT
$119M
| $504K | ﹤0.01% |
43,274
+12,753
| +42% | +$180K |
2025 Q4
1 quarter
|
|
9243
PUT
Intapp
INTA
$2.83B
| $504K | ﹤0.01% |
19,600
-10,900
| -36% | -$325K |
2022 Q4
13 quarters
|
|
9244
Franklin Focused Dynamic Growth ETF
FFOG
$388M
| $503K | ﹤0.01% |
+12,255
| New | +$541K |
2026 Q1
0 quarters
|
|
9245
Fidelity High Yield Factor ETF
FDHY
$616M
| $503K | ﹤0.01% |
+10,370
| New | +$511K |
2026 Q1
0 quarters
|
|
9246
CALL
SLM Corp
SLM
$4.25B
| $503K | ﹤0.01% |
23,500
+700
| +3% | +$16.5K |
2017 Q4
33 quarters
|
|
9247
Fortress Biotech
FBIO
$68.4M
| $503K | ﹤0.01% |
+180,289
| New | +$613K |
2026 Q1
0 quarters
|
|
9248
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
| $503K | ﹤0.01% |
+4,582
| New | +$520K |
2026 Q1
0 quarters
|
|
9249
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$153M
| $502K | ﹤0.01% |
4,500
-2,100
| -32% | -$218K |
2017 Q4
33 quarters
|
|
9250
Citizens & Northern Corp
CZNC
$456M
| $502K | ﹤0.01% |
22,473
-12,624
| -36% | -$280K |
2024 Q2
7 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.